Mohammed Irshad, MD
Gastroenterology · Clinton, IANPI 1508854589
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $12,439 of the $18,342 with a category attached, or 67.8%. Celltrion USA Inc. accounts for 70.6% of it on its own, with 22 other manufacturers making up the rest. 2025 is the largest year on record at $13,545, 9.7 times the $1,403 reported in 2019. Among gastroenterology clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 163 payments — averaging $112.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Celltrion USA Inc.$13K
- AbbVie$2K
- Boston Scientific$661
- Johnson & Johnson$553
- Phathom Pharmaceuticals, Inc.$367
- Takeda Pharmaceuticals U.S.A., Inc.$359
- plus $2K from 17 others
What the payments were for
- Speaking & faculty fees$12,43968%
- Travel & lodging$6203%
- Food & beverage$5,12628%
- Education$1561%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Celltrion USA Inc. | 15 | $12,944 |
| AbbVie(2 entities) | 39 | $1,751 |
| Boston Scientific | 18 | $661 |
| Johnson & Johnson | 23 | $553 |
| Phathom Pharmaceuticals, Inc. | 6 | $367 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $359 |
| Janssen Scientific Affairs, LLC | 3 | $237 |
| Gilead | 6 | $234 |
| Daiichi Sankyo Inc. | 1 | $215 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $203 |
| Sanofi | 2 | $150 |
| Ferring Pharmaceuticals Inc. | 1 | $116 |
| Madrigal Pharmaceuticals | 1 | $116 |
| Pfizer | 1 | $91 |
| Shire North American Group Inc | 6 | $89 |
| E.r. Squibb & Sons, L.L.C. | 1 | $80 |
| Braintree Laboratories, Inc. | 3 | $47 |
| Medtronic | 2 | $36 |
| Aimmune Therapeutics, Inc. | 1 | $22 |
| Ardelyx, Inc. | 1 | $20 |
| UCB, Inc. | 1 | $19 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| Olympus America Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$18,342 in reported general payments places this provider in the 95th percentile of 113 gastroenterology providers in Iowa.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GattexTeduglutide | 11 | $506,837 |
| StelaraUstekinumab | 15 | $400,899 |
| Mesalamine | 11 | $14,580 |
| Colesevelam Hcl | 13 | $1,099 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 17 | $1,023 |
| Pantoprazole Sodium | 86 | $576 |
| Omeprazole | 30 | $487 |
| Rabeprazole Sodium | 11 | $385 |
| Lactulose | 12 | $63 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Gattex | $359 | $506,83711 claims |
| Johnson & JohnsonStelara | $553 | $400,89915 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 113 gastroenterology providers in Iowa.
Other gastroenterology in Clinton
- Ahmed ElahmadyClinton$5K
- Nagendra MyneniClive$66K
- Ryan PerumpailBettendorf$62K
- Richard ManfreadyWaterloo$56K
- Maen MasadehIowa City$24K
- John HerlihyCedar Rapids$13K
- Bernard LemanClive$12K
- Archana VermaClive$6K
- Daniel PeasleyWest Burlington$6K
- Christopher MulderClive$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.